VYNE Therapeutics (VYNE) Misses Q1 EPS by 20c

VYNE Therapeutics (NASDAQ: VYNE) reported Q1 EPS of ($0.20). Revenue for the quarter came in at $200 thousand.

For earnings history and earnings-related data on VYNE Therapeutics (VYNE) click here.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• ShinyHunters hackers say they stole psychiatric and medical records of DBI staff - Reuters
• Freedom Broker Starts Autoliv, Inc. (ALV) at Buy